Earnings (Loss) Per Share (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2020

Dec. 31, 2019

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The following table sets forth the computation of basic and diluted loss for the nine months (in thousands, except for share and per share amounts):

	Nine Months ended September 30,
	2020			2019
Numerator:
Net loss	$	(72,227	)	$	(76,774	)
Deemed dividend attributable to BCF		(6,247	)		(5,282	)
Net loss attributable to common shareholders	$	(78,474	)	$	(82,056	)
Denominator:
Weighted average Common shares outstanding- Basic		9,510,996			8,676,669
Dilutive effect of potential common shares		—			—
Weighted average Common shares outstanding- Diluted		9,510,996			8,676,669
Net loss per shares attributable to Common shareholders-Basic and Diluted	$	(8.25	)	$	(9.46	)

The following table sets forth the computation of basic and diluted loss (in thousands, except for share and per share amounts):

	As of December 31,
	2019			2018
Numerator:
Net loss	$	(94,718	)	$	(79,550	)
Deemed dividend attributable to BCF accretion		(5,282	)		—
Net loss attributable to common shareholders		(100,000	)		(79,550	)
Denominator:
Weighted average Common shares outstanding- Basic		8,718,104			6,631,873
Dilutive effect of potential common shares		—			—
Weighted average Common shares outstanding- Diluted		8,718,104			6,631,873
Net loss per shares attributable to Common shareholders- Basic and Diluted	$	(11.47	)	$	(12.00	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock for the periods presented because including them would have been antidilutive:

	Nine Months ended September 30,
	2020		2019
Warrants		444,023		71,281
Stock options		1,199,974		148,988
Restricted Stock		161,549		542,610
Series A Convertible Preferred Stock		6,956,100		6,956,100
Series X Convertible Preferred Stock		1,251,971		—
Founders Preferred Stock		1,922,600		1,922,600
Total		11,936,217		9,641,579

The following table presents the potential shares of Common Stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:

	As of December 31,
	2019		2018
Warrants		71,281		71,281
Stock Options		365,938		—
Restricted Stock		460,257		1,693,491
Series A Convertible Preferred Stock		6,956,100		—
Founders Preferred Stock		1,922,600		1,922,600
SAFE		—		4,488,738
Total		9,776,176		8,176,110